Latest Psychedelic News

Zoë Meyers/inewsource

La Jolla clinic laments loss of authorization for ketamine treatments for veterans with depression

Science & Research

Kadima founder & medical director Dr. David Feifel has been using ketamine to treat veterans with depression for more than 10 years, many with referrals from VA

July 28, 2020
ASHLEY MACKIN-SOLOMON
DoTheBay

How the “Most Normal Person Ever” Became the Face of a Movement to Decriminalize Magic Mushrooms

Psychedelic Reform

For Melissa Lavasani, salvation arrived after listening to mycologist Paul Stamets speak to Joe Rogan about the benefits of psilocybin on mental health

July 28, 2020
Andrew Beaujon
Netflix

Ecstasy May Be The Answer To PTSD Reveals Netflix's Business of Drugs

Psychedelic Reform

Netflix's The Business of Drugs reveals that MDMA (aka "Ecstasy" or "Molly") can be used to effectively treat PTSD.

July 28, 2020
Q.V. Hough
NeuroCosm

60-Plus Psychedelic Clinical Trials Listed on Online Directory

Psychedelic Reform

As the number of psychedelic clinical trials increases at a steep pace, it can be difficult for prospective volunteers to find one that’s best suited for them.

July 23, 2020
Faye Sakellaridis
Champignon Brands

Champignon Brands Files BAR Reports Signal Beginning of End to Stock Halt

Investor News

Champignon Brands Inc. (OTCMKTS:SHRMF) investors can finally breathe a sigh of (partial) relief.

July 23, 2020
Benjamin Smith
Benzinga

ATAI Launches Subsidiary Focused On Active Ingredient In Hallucinogenic Brews

Investor News

Psychedelics and biotech company ATAI Life Sciences announced Wednesday the launch of Viridia Life Sciences.

July 23, 2020
Natan Ponieman
JHPsychedelics

INSIGHT NETWORK: Diving deep with Matthew W. Johnson

Psychedelic Reform

Dr. Johnson discusses how certain drugs affect decision making, time horizons, & reward sensitivity, to intersection of religious traditions & clinical practice

July 23, 2020
Allan Malievsky
Shutterstock

Psychedelic Assisted Psychotherapy and Experiential Efficacy

Science & Research

With the paradigm shift created by psychedelics, a recent study suggests reconsidering the medical model of mental illness.

July 23, 2020
David Sugarbaker, PSYD, MPH